FDA impressed by AI-powered blood test | Comparing TAVR valves | A big approval for GE HealthCare | New HCM drug delivers

The FDA clearly sees significant potential in a new multi-protein blood test from Prevencio. The company's goal is to gain full approval and get the test in the hands of emergency departments all over the United States.

Andreas Ruck, MD, discussed new registry data on Boston Scientific’s Acurate neo2 TAVR valve, comparing it to popular devices from Edwards Lifesciences and Medtronic.

Unlike other UEA options, GE HealthCare's Optison does not contain polyethylene glycol. The FDA approved its use for adult patients back in 1997.

Cytokinetics announced positive results from a new clinical trial comparing aficamten monotherapy to the beta blocker metoprolol.

When a patient’s TAVR valve fails, redo TAVR is not always a feasible option. TAVR explantation and SAVR are typically the answer in these cases, but that approach is associated with certain risks. 

The new 1.5T MRI scanner includes a wide bore and key AI features designed to boost the patient experience.

The two groups stressed that tariffs would likely impact patient care.

Both operations can help obese patients lose weight, researchers noted, but gastric bypass surgery "may be associated with greater cardiovascular benefits."

The new resource was built to help care teams plan for ascending aorta and aortic root surgeries.

Pulsed field ablation was one of the biggest topics at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society. Medtronic, Johnson & Johnson MedTech, Boston Scientific, Abbott, Kardium and Field Medical all shared new data at the conference highlighting the safety and effectiveness of their advanced PFA technologies. 

Medtronic emphasized that this device should be especially valuable when treating younger patients or those with a small anatomy.

For some, the FDA is moving too fast in its drive to adopt generative AI agency-wide. 

These findings could be beneficial for women with dense breasts, which increase the risk of developing cancer while making it significantly more difficult to detect.